Yudi Duan
Overview
Explore the profile of Yudi Duan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yan P, Yang K, Xu M, Zhu M, Duan Y, Li W, et al.
J Mol Cell Biol
. 2024 May;
16(5).
PMID: 38760881
Idiopathic pulmonary fibrosis (IPF) is a lethal progressive fibrotic lung disease. The development of IPF involves different molecular and cellular processes, and recent studies indicate that lactate plays a significant...
2.
Wan R, Long S, Ma S, Yan P, Li Z, Xu K, et al.
Respir Res
. 2024 Apr;
25(1):154.
PMID: 38566093
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal, and aging-associated interstitial lung disease with a poor prognosis and limited treatment options, while the pathogenesis remains elusive. In this study,...
3.
Wan R, Wang L, Zhu M, Li W, Duan Y, Yu G
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003600
Pulmonary fibrosis (PF) is a chronic interstitial lung disease characterized by myofibroblast abnormal activation and extracellular matrix deposition. However, the pathogenesis of PF remains unclear, and treatment options are limited....
4.
Wan R, Wang L, Duan Y, Zhu M, Li W, Zhao M, et al.
Cell Death Discov
. 2023 Nov;
9(1):407.
PMID: 37923730
Idiopathic pulmonary fibrosis is a progressive and fatal interstitial lung disease with a poor prognosis and limited therapeutic options, which is characterized by aberrant myofibroblast activation and pathological remodeling of...